UK Markets closed
NIKKEI 225
27,466.61 +520.94 (+1.93%) HANG SENG
19,591.43 +332.67 (+1.73%) CRUDE OIL
70.41 +0.74 (+1.06%) GOLD FUTURES
1,951.80 +10.70 (+0.55%) DOW
32,470.03 -90.57 (-0.28%) BTC-GBP
22,256.44 -669.67 (-2.92%)
BIOXXMED AG INH O.N. (T5O.DU)
Dusseldorf - Dusseldorf Delayed price. Currency in EUR
Add to watchlist
At close: 05:30PM CET
| Previous close | 2.3800 |
| Open | 2.3800 |
| Bid | 2.3000 x 0 |
| Ask | 2.7200 x 0 |
| Day's range | 2.3800 - 2.5000 |
| 52-week range | 0.9360 - 4.7900 |
| Volume | |
| Avg. volume | 32 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- EQS Group
Centaur Pharmaceuticals Pvt Ltd increases sales with Woxheal® - ongoing open label marketing study in numerous Indian centres AG:
EQS-News: bioXXmed AG / Key word(s): MiscellaneousCentaur Pharmaceuticals Pvt Ltd increases sales with Woxheal® - ongoing open label marketing study in numerous Indian centres AG: 03.02.2023 / 08:09 CET/CESTThe issuer is solely responsible for the content of this announcement.Centaur Pharmaceuticals Pvt Ltd increases sales with Woxheal® - ongoing open label marketing study in numerous Indian centresDarmstadt, 2nd February, 2023 - The Management Board of bioXXmed AG and Centaur Pharmaceuticals cr
© 2023 Yahoo. All rights reserved.
